Results 51 to 60 of about 10,214,758 (341)
Inflammation, Atherosclerosis and Coronary Artery Disease
Clinical Medicine Insights: Cardiology, 2014 Article types include original clinical and basic research articles, case reports, commentaries, meeting reports, methodology, perspectives. Research into inflammation, atherosclerosis and coronary artery disease, including observational studies ...
Y. Momiyama +4 more
semanticscholar +1 more source
Central Dysmyelination in SSADH‐Deficient Humans and Mice
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives Succinic semialdehyde dehydrogenase deficiency (SSADHD) is an inherited metabolic disorder characterized by an accumulation of γ‐aminobutyric (GABA). In addition to its synaptic role as an inhibitory neurotransmitter, GABA also plays an important role in myelination.
Itay Tokatly Latzer +11 more
wiley +1 more source
BMC Cardiovascular Disorders, 2019 Background The association between mean platelet volume (MPV) and coronary plaque vulnerability in patients with non-ST-elevation ACS (NSTE-ACS) has not been investigated.
Jun Wang +7 more
doaj +1 more source
Coronary disease and anaesthesia [PDF]
Anaesthesia, 1980 SummaryThe anaesthetic care of patients with coronary artery disease can probably be improved. The goal is to maintain a favourable myocardial oxygen supply/demand ratio. This may necessitate the use of β‐blockade and vasodilators, or alternatively perhaps halothane, in order to reduce arterial pressure and heart rate, and thereby reduce myocardial ...
openaire +3 more sources
Effects of Non‐Aspirin Nonsteroidal Anti‐Inflammatory Drugs on Acute Intracerebral Hemorrhage
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Despite celecoxib, a cyclooxygenase‐2 inhibitor, promoting functional recovery from intracerebral hemorrhage (ICH) by reducing inflammation‐mediated perihematomal edema in rat models, the evidence of its effects on patient outcomes remains limited.
Shin‐Joe Yeh +3 more
wiley +1 more source
Inflammation, atherosclerosis, and coronary artery disease.
New England Journal of Medicine, 2005 ecent research has shown that inflammation plays a key role in coronary artery disease (CAD) and other manifestations of atherosclerosis. Immune cells dominate early atherosclerotic lesions, their effector molecules accelerate progression of the lesions,
G. Hansson
semanticscholar +1 more source
Metabolic Consequences of Rheumatoid Arthritis
Arthritis Care &Research, EarlyView.Patients with rheumatoid arthritis (RA) may have metabolic disruption, which can contribute to adverse long‐term outcomes, for multiple reasons. Patients with RA appear to have a higher risk of sarcopenia, type 1 and type 2 diabetes mellitus, metabolic syndrome, and hypertension. Systemic inflammation in RA can cause a “lipid paradox,” with reduced low‐
Stevie Barry +2 more
wiley +1 more source
CORONARY DISEASE: Intervention in coronary artery disease [PDF]
Heart, 2000 Percutaneous transluminal coronary angioplasty (PTCA) was introduced into clinical practice more than 20 years ago.1 The breathtaking growth of percutaneous coronary interventions (PCI) during the 1990s in Europe (fig 1) reflects their widespread acceptance for coronary revascularisation, challenging coronary artery bypass grafting (CABG).
Bernhard Meier, Stephan Windecker
openaire +3 more sources
Arthritis Care &Research, Accepted Article.Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim +18 more
wiley +1 more source
BMC Cardiovascular DisordersBackground The prognostic significance of obstructive sleep apnea (OSA) in patients with unstable angina (UA) based on remnant cholesterol (RC) or triglyceride (TG) levels remains unclear.
Yun Zhou +13 more
doaj +1 more source